DNMT1 and arthritic joint disease: IDO1 gene expression can be inhibited by DNA methylation at the promoter, and treating mice with experimental arthritis with the DNA methyl-transferase (DNMT) inhibitor decitabine reduced the symptoms of arthritis and prevented the occurrence of relapse, in an IDO-dependent manner [74].